Citadel Advisors
ALHC icon

Citadel Advisors’s Alignment Healthcare ALHC Stock Holding History

Citadel Advisors’s Portfolio ALHC Stock Details ALHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$518K Buy
+29,400
New +$590K ﹤0.01% 9215
2025
Q4 		– Sell
-49,200
Closed -$859K – 12561
2025
Q3 		$859K Buy
49,200
+19,600
+66% +$291K ﹤0.01% 7874
2025
Q2 		$414K Sell
29,600
-27,600
-48% -$444K ﹤0.01% 9075
2025
Q1 		$1.07M Sell
57,200
-7,400
-11% -$110K ﹤0.01% 6824
2024
Q4 		$727K Buy
+64,600
New +$755K ﹤0.01% 7733
2024
Q3 		– Sell
-1,100
Closed -$8.6K – 14159
2024
Q2 		$8.6K Buy
1,100
+400
+57% +$2.61K ﹤0.01% 13178
2024
Q1 		$3.47K Sell
700
-3,000
-81% -$19.2K ﹤0.01% 13899
2023
Q4 		$31.9K Sell
3,700
-5,600
-60% -$41K ﹤0.01% 12216
2023
Q3 		$64.5K Buy
+9,300
New +$56.1K ﹤0.01% 11434
2023
Q1 		– Sell
-11,200
Closed -$132K – 14656
2022
Q4 		$132K Buy
+11,200
New +$136K ﹤0.01% 10811
2021
Q3 		– Sell
-11,100
Closed -$259K – 13739
2021
Q2 		$259K Buy
+11,100
New +$270K ﹤0.01% 11619

Other funds holding ALHC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Citadel Advisors's ALHC Position: Q1 2026 in Review

Citadel Advisors increased its Alignment Healthcare (ALHC) stake by 24% in Q1 2026, buying an estimated $20.5M and bringing the position to 5,362,666 shares worth $94.5M. The position accounts for 0.02% of the portfolio, ranked #845.

Citadel Advisors first reported a position in ALHC in Q2 2021 and has held it in 18 quarters since. The position peaked at $117M in Q2 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • Citadel Advisors held 5,362,666 shares of Alignment Healthcare worth $94.5M as of Q1 2026.
  • Citadel Advisors bought 1,021,800 Alignment Healthcare shares in Q1 2026, an estimated $20.5M.
  • Alignment Healthcare made up 0.02% of Citadel Advisors's portfolio in Q1 2026, its #845 holding.
  • Citadel Advisors first reported a position in Alignment Healthcare in Q2 2021 and has held it in 18 quarters since.
  • Citadel Advisors's Alignment Healthcare position peaked at $117M in Q2 2025.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.